Barbara Maria Socha

Dr. Barbara Maria Socha

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Domestic Animal Endocrinology
Verified
Journal Article
Closed access
MŁM. Łupicka
M. Łupicka
BSBarbara Maria Socha
Barbara Maria Socha
ASAgata Szczepańska
Agata Szczepańska
AKAnna KORZEKWA
Anna KORZEKWA

1 January 2013 in Theriogenology
Verified
Journal Article
Closed access
AKAnna KORZEKWA
Anna KORZEKWA
MBMamadou M. Bah
Mamadou M. Bah
MGMałgorzata Gęstwicka
Małgorzata Gęstwicka
BSBarbara Maria Socha
Barbara Maria Socha
Dariusz Jan SkarzynskiDariusz Jan Skarzynski
Dariusz Jan Skarzynski

1 December 2018 in Theriogenology
Verified
Journal Article
Closed access
BSBarbara Maria Socha
Barbara Maria Socha
PŁP. Łada
P. Łada
ASAgata Szczepańska
Agata Szczepańska
MŁM. Łupicka
M. Łupicka
AKAnna KORZEKWA
Anna KORZEKWA

1 December 2016 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
AKAnna KORZEKWA
Anna KORZEKWA
MŁM. Łupicka
M. Łupicka
BSBarbara Maria Socha
Barbara Maria Socha
ASAgata Szczepańska
Agata Szczepańska
Ewa PiotrowiczEwa Piotrowicz
Ewa Piotrowicz
WBWojciech Barański
Wojciech Barański

1 September 2017 in Theriogenology
Verified
Journal Article
Closed access
BSBarbara Maria Socha
Barbara Maria Socha
MŁM. Łupicka
M. Łupicka
ASAgata Szczepańska
Agata Szczepańska
AKAnna KORZEKWA
Anna KORZEKWA

29 September 2015 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
MŁMartyna Łupicka
Martyna Łupicka
BSBarbara Maria Socha
Barbara Maria Socha
ASAgata Szczepańska
Agata Szczepańska
AKAnna KORZEKWA
Anna KORZEKWA
Adenomyosis is a proliferative uterine dysfunction with unknown aetiology. One possible mechanism of its development involves disturbances in stem cell differentiation in uterine tissue. Previously, we identified pluripotent/multipotent cells in the bovine uterus, therefore our present study focused on determining expression of pluripotency markers, NANOG, OCT4 and SOX2, in bovine adenomyotic tissues and cells. Immunolocalisation revealed protein expression of NANOG, OCT4 and SOX2 in both normal and adenomyotic uteri. mRNA expression for NANOG and OCT4 was increased in tissues obtained from uteri with adenomyosis compared to controls, but at the protein level there were no significant differences. mRNA expression for all three pluripotency markers was higher in myometrial cells isolated from uteri with adenomyotic lesions than in those isolated from normal uteri. The protein level of NANOG and SOX2 was decreased in stromal cells from adenomyotic tissues, whereas the level of OCT4 and SOX2 was increased in myometrial cells obtained from dysfunctional uteri. The results indicate significant changes in expression of pluripotency markers in adenomyotic compared to normal uteri, which suggest the involvement of uterine stem cells in adenomyosis.